Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy

IMPORTANCE: The risk of extraocular extension from injecting chemotherapy into eyes with retinoblastoma is minimally understood; however, understanding this risk is important because of the increasing use of intravitreous chemotherapy. OBJECTIVE: To evaluate the risk of extraocular extension in eyes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA ophthalmology 2017-12, Vol.135 (12), p.1426-1429
Hauptverfasser:	Francis, Jasmine H, Abramson, David H, Ji, Xunda, Shields, Carol L, Teixeira, Luiz F, Schefler, Amy C, Cassoux, Nathalie, Hadjistilianou, Doris, Berry, Jesse L, Frenkel, Shahar, Munier, Francis L
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Brief Report Child, Preschool Cryotherapy Female Humans Infant Intravitreal Injections Male Melphalan - administration & dosage Methotrexate - administration & dosage Microscopy, Acoustic Neoplasm Seeding Online First Retinal Neoplasms - drug therapy Retinal Neoplasms - pathology Retinoblastoma - drug therapy Retinoblastoma - secondary Retrospective Studies Risk Factors Topotecan - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!